There is an urgent need for the discovery of effective new antimicrobial agents to combat the rise of bacterial drug resistance. High-throughput screening (HTS) in whole-animal infection models is a powerful tool for identifying compounds that show antibacterial activity and low host toxicity. In this report, we characterize the activities of four novel antistaphylococcal compounds identified from an HTS campaign conducted using Caenorhabditis elegans nematodes infected with methicillin-resistant Staphylococcus aureus (MRSA). The hit compounds included an Nhydroxy indole-1, a substituted melamine derivative-2, N-substituted indolic alkyl isothiocyanate-3, and pdifluoromethylsulfide analog-4 of the well-known protonophore carbonyl cyanide m-chlorophenyl hydrazone. Minimal inhibitory concentrations (MICs) of the four compounds ranged from 2 to 8 μg/ml against MRSA-MW2 and Enterococcus faecium and all were bacteriostatic. The compounds were mostly inactive against Gram-negative pathogens, with only 1 and 4 showing slight activity (MIC= 32 μg/ml) against Acinetobacter baumanii. Compounds 2 and 3 (but not 1 or 4) were found to perturb MRSA membranes. In phagocytosis assays, compounds 1, 2, and 4 inhibited the growth of internalized MRSA in macrophages, whereas compound 3 showed a remarkable ability to clear intracellular MRSA at its MIC ( p < 0.001). None of the compounds showed hemolytic activity at concentrations below 64 μg/ml ( p = 0.0021). Compounds 1, 2, and 4 (but not 3) showed synergistic activity against MRSA with ciprofloxacin, while compound 3 synergized with erythromycin, gentamicin, streptomycin, and vancomycin. In conclusion, we describe four new antistaphylococcal compounds that warrant further study as novel antibacterial agents against Gram-positive organisms.
Introduction
(http://www.cellprofiler.org/). The ratio of Sytox worm area to bright field worm area and the 88 resultant percentage survival data were calculated by the software for each well 9 . Assays were 89 completed in duplicate. Antibacterial susceptibility assays. In vitro antibacterial activities were tested using the broth 100 microdilution method 12 . Assays were carried out in triplicate using Müller-Hinton broth (BD Time to kill assays. The antibacterial properties of 1-4 against MRSA-MW2 were further 110 examined using time to kill assays, as previously described 14 . Briefly, overnight cultures of S. 111 aureus MW2 were diluted in fresh TSB to a density of 10 8 cells/mL and placed into 10 mL tubes 112 (BD Biosciences). Test compounds at 4x MIC were added and the tubes incubated at 37 °C, with 113 agitation. Aliquots were periodically drawn from the tubes over a 4 h period, serially diluted with 114 TSB and plated onto tryptic soy agar (TSA; BD Biosciences). CFUs were then enumerated after 115 overnight incubation at 37 °C. Assays were carried out in triplicate.
116
Membrane permeabilization assays. Sytox Green (Life Technologies, Carlsbad, CA, USA) was 117 used to probe the effects of 1-4 on MRSA-MW2 membrane permeabilization, as previously 118 described 15 . Assays were carried out in duplicate in 96 wells plates (Corning). Bacterial cells were 119 harvested from logarithmically growing cultures by centrifugation at 3724 g for 5 minutes, washed 120 twice with phosphate buffered saline (PBS, pH 7.4) and resuspended in PBS to OD595 nm = 0.2.
121
Sytox Green was added at a final concentration of 5 µM and cells were incubated in the dark for When cells were exposed to the compounds at 4X MIC all showed only bacteriostatic activity 193 relative to DMSO controls (Figure 3) . While compounds 1, 2 and 4 inhibited bacterial growth, 194 ITC derivative 3 was able to reduce CFU/mL counts by 2-log10. to bacterial cells in time to kill kinetics. However, we treated MRSA-MW2 cells with compounds 213 1-4, and incubated as indicated in the macrophage assay and we observed that compound 3 killed 214 the planktonic bacteria after prolonged incubation (Figure 5B) . 215 Human red blood cell lysis assays and cytotoxicity. Serial dilutions of 1-4 were added to human 216 red blood cells to establish whether they show hemolytic activity. It was found that none of the 217 compounds showed hemolysis at concentrations up to 64 µg/mL. Serially diluted triton-X (0.001 218 to 1%) as a positive control were added to human RBCs caused substantial lysis (Figure 6A) .
used to test the toxicity of compounds 14 . In this series of experiments, the IC50 of the compound 221 1-4 against HepG2 was 32, 16, 8, and 1 µg/mL respectively (Figure 6B ). Also, we tested the 222 cytotoxicity with gastric and renal cell lines and we observed similar results with hepatic cell lines.
223
The IC50 of compounds 1-4 was against MKN-28 was 64, 32, 4 and 4 µg/mL respectively (Figure   224 6C); and against HKC-8 was 64, 32, 2, 2 µg/mL respectively (Figure 6D) . The IC50 of compounds Synergy FICI ≤ 0.5, antagonism FICI > 4.0, no interaction 0.5 > FICI ≤ 4.0 28 .
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